SNX281 is a systemically active STING agonist that binds to the STING protein, promotes signal transduction of the cGAS-STING pathway, and increases cellular responses to tumor cells. SNX281 can be used in the study of anti-tumor immunity.
References:
[1]. Catherine SCHOLZ, et al. Biomarkers for sting agonists and methods of using the same. WO2023039363A1.2022-09-02
















